A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients’ networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of famili...
Parkinson’s disease (PD) is the most frequently occurring movement disorder, with an increasing inci...
Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset, autosomal dominant Parkinson's...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Dopaminergic neurons (DAn) were efficiently differentiated from 6 different iPSC lines derived from ...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
SummaryStudies of Parkinson's disease (PD) have been hindered by lack of access to affected human do...
SummaryMutations in leucine-rich repeat kinase 2 (LRRK2) are the most-common genetic determinants of...
The principal hallmark of Parkinson's disease (PD) is the selective neurodegeneration of dopaminergi...
While induced pluripotent stem cell (iPSC) technologies enable the study of inaccessible patient cel...
Parkinson disease (PD) is the most common movement disorder and the second most common age-related p...
The identification of the leucine-rich repeat kinase 2 (LRRK2) gene was a breakthrough in the area o...
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by motor dysfunc...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of famili...
Parkinson’s disease (PD) is the most frequently occurring movement disorder, with an increasing inci...
Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset, autosomal dominant Parkinson's...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Dopaminergic neurons (DAn) were efficiently differentiated from 6 different iPSC lines derived from ...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
SummaryStudies of Parkinson's disease (PD) have been hindered by lack of access to affected human do...
SummaryMutations in leucine-rich repeat kinase 2 (LRRK2) are the most-common genetic determinants of...
The principal hallmark of Parkinson's disease (PD) is the selective neurodegeneration of dopaminergi...
While induced pluripotent stem cell (iPSC) technologies enable the study of inaccessible patient cel...
Parkinson disease (PD) is the most common movement disorder and the second most common age-related p...
The identification of the leucine-rich repeat kinase 2 (LRRK2) gene was a breakthrough in the area o...
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by motor dysfunc...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of famili...
Parkinson’s disease (PD) is the most frequently occurring movement disorder, with an increasing inci...
Mutations in leucine-rich repeat kinase 2 (LRRK2) lead to late-onset, autosomal dominant Parkinson's...